R&D Day 2020 - tells market 002 study will conclude end Q1 2023.
006 study to conclude Q3 2023.
Gets 7 months of FDA IND delays. Tells market that they will initiate new sites to make up delay time.
Drops presentation to say 002 and 006 will be 18 months delay.
You can't make this stuff up.
Ann: Paradigm Presentation for Investor Webinar, page-4
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
24.0¢ |
Change
-0.005(2.04%) |
Mkt cap ! $83.98M | |||
| Open | High | Low | Value | Volume |
| 25.0¢ | 25.5¢ | 24.0¢ | $202.2K | 814.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 181098 | 24.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 25.0¢ | 118621 | 5 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| PAR (ASX) Chart |